))
Health Canada approves Wegovy to reduce risk of heart attacks
Manage episode 452512485 series 3546736
Kandungan disediakan oleh Dr. Sue Pedersen. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Dr. Sue Pedersen atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Yesterday, Health Canada approved semaglutide 2.4mg (Wegovy) to reduce the risk of heart attacks in people with cardiovascular disease and overweight or obesity. This is a landmark moment in Canada. What does it mean for people with overweight or obesity and cardiovascular disease? Find out Dr. Sue's thoughts here!
Learn more: https://drsue.ca/2024/11/health-canada-approves-wegovy-to-reduce-risk-of-heart-attacks/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.
57 episod
Kongsi
